WCN26-6465 APPLICATION OF TRF-BUDESONIDE(NEFECON) IN THE TREARMENT OF PEDIATRIC PATIENT WITH IGA NEPHROPATHY: A CASE REPORT

Read full text Summarise with VIRAT
Authors: Xinyi Zhu, Tong Yiming, Yan Ouyang, Jing Xu, Xiaofan Hu, Xiaoxia Pan, Lei Yin, Jingyuan Xie
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Immunoglobulin A nephropathy (IgAN) is one of the most common primary glomerular diseases in children and adolescents, with 20% of affected children progressing to end-stage kidney disease (ESKD) within 20 years of diagnosis. While glucocorticoids are used in adult IgAN to protect renal function, their systemic toxicity is a concern, and there is no consensus on their use in pediatric IgAN due to insufficient evidence and population differences. The pathogenesis of IgAN is not fully understood, but growing evidence highlights the role of the gastrointestinal mucosal immune system.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Vasculitis and related conditions Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105759–105759
Publication date
25 March 2026
Language
EN